Wogonin has multiple anti-cancer effects by regulating c-Myc/SKP2/ Fbw7α and HDAC1/HDAC2 pathways and inducing apoptosis in human lung adenocarcinoma cell line A549

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Chen, Xin Mei ^a   Bai, Yang ^b   Zhong, Yu Jian ^a   Xie, Xiao Lin ^c   Long, Han Wu ^c   Yang, Yu Yin ^c   Wu, Shi Gen ^c   Jia, Qiang ^c   Wang, Xiao Hua ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^c GUIZHOU ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; F-BOX PROTEINS; FLAVANONES; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOGEN SYNTHASE KINASE 3; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HUMANS; LUNG NEOPLASMS; MEMBRANE POTENTIAL, MITOCHONDRIAL; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; S-PHASE KINASE-ASSOCIATED PROTEINS; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 84893368118     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079201     Document Type: Article

References (42)

1. Juergens R, Brahmer J (2007) Targeting the epidermal growth factor receptor in non-small-cell lung cancer: who, which, when, and how? Curr Oncol Rep 4: 255-264.
2. Crocetti E, Paci E (2002) Trends in lung adenocarcinoma incidence and survival, Lung Cancer 2: 215-216.
3. Ruthenburg AJ, Li H, Patel DJ, Allis CD (2007) Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol 8: 983-994. (Pubitemid 350174643)
4. Marks PA, Xu WS (2009) Histone deacetylase inhibitors: potential in cancer therapy, J Cell Biochem 107: 600-608.
5. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. BioChem J 370: 739-749.
6. Dang CV, Resar LM, Emison E, Kim S, Li Q, et al. (1999) Function of the c-Myc oncogenic transcription factor. Exp Cell Res 253: 63-77.
7. Kelly K, Cochran H, Stiles CD, Leder P (1983) Cell-specific regulation of the c-Myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35: 603-610.
8. Flinn EM, Busch CM, Wright AP (1998) Myc boxes, which are conserved in Myc family proteins, are signals for protein degradation via the proteasome. Mol Cell Biol 18: 5961-5969.
9. Jones TR, Cole MD (1987) Rapid cytoplasmic turnover of c-Myc mRNA: requirement of the 3′ untranslated sequences. Mol Cell Biol 7: 4513-4521.
10. Nesbit CE, Tersak JM, Prochownik EV (1999) MYC oncogenes and human neoplastic disease. Oncogene 18: 3004-3016. (Pubitemid 29276540)
11. Amati B (2004) Myc degradation: dancing with ubiquitin ligases. Proc Natl Acad Sci 101: 8843-8844.
12. Chan CH, Morrow JK, Li CF, Gao Y, Jin G, et al. (2013) Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression. Cell 3: 556-68.
13. Carrano AC, Eytan E, Hershko A, Pagano M (1999) Skp2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1: 193-199.
14. Kamura T, Hara T, Kotoshiba S, Yada M, Ishida N, et al. (2003) Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation. Proc Natl Acad Sci 100: 10231-10236.
15. Tedesco D, Lukas J, Reed SI (2002) The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). Genes Dev 16: 2946-2957.
16. Hiramatsu Y, Kitagawa K, Suzuki T, Uchida C, Hattori T, et al. (2006) Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination. Cancer Res 66: 8477-8483.
17. Zhao D, Zheng HQ, Zhou Z, Chen C (2010) The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation. Cancer Res 70: 4728-4738.
18. Akhoondi S, Lindstrom L, Widschwendter M, Corcoran M, Bergh J, et al. (2010) Inactivation of FBXW7/hCDC4-beta expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer. Breast Cancer Res 12: R105.
19. Inuzuka H, Shaik S, Onoyama I, Gao D, Tseng A, et al. (2011) SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature 471: 104-109.
20. Sancho R, Jandke A, Davis H, Diefenbacher ME, Tomlinson I, et al. (2010) Fbox and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor. Gastroenterology 139: 929-941.
21. O'Neil J, Look AT (2007) Mechanisms of transcription factor deregulation in lymphoid cell transformation. Oncogene 26: 6838-6849. (Pubitemid 47585107)
22. Wang Z, Fukushima H, Gao D, Inuzuka H, Wan L, et al. (2011) The two faces of FBW7 in cancer drug resistance. Bioessays 11: 8512859.
23. Wertz IE, Kusam S, Lam C, Okamoto T, Sandoval W, et al. (2011) Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature 471: 110-114.
24. Pulverer BJ, Fisher C, Vousden K, Littlewood T, Evan G, et al. (1994) Sitespecific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene 9: 59-70. (Pubitemid 24020934)
25. Kim SY, Herbst A, Tworkowski KA, Salghetti SE, Tansey WP (2003) Skp2 regulates Myc protein stability and activity. Mol Cell 11: 1177-1188.
26. Spruck CH, Strohmaier H, Sangfelt O, Müller HM, Hubalek M, et al. (2002) hCDC4 gene mutations in endometrial cancer. Cancer Res 62: 4535-4539.
27. Welcker M, Orian A, Grim JE, Eisenman RN, Clurman BE (2004) A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size. Curr Biol 14: 1852-1857.
28. Chi YS, Cheon BS, Kim HP (2001) Effect of wogonin, a plant flavone from Scutellaria radix, on the suppression of cyclooxygenase-2 and the induction of inducible nitric oxide synthase in lipopolysaccharide-treated RAW 264.7 cells. Biochem Pharmacol 61: 1195-1203.
29. Li-Weber M (2009) New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents wogonin, baicalein and baicalin. Cancer Treat Rev 35: 57-68.
30. Zhang M, Liu LP, Chen Y, Tian XY, Qin J, et al. (2013) Wogonin induces apoptosis in RPMI 8226, a human myeloma cell line, by downregulating phospho-Akt and overexpressing Bax. Life Sci 1: 55-62.
31. Chen YC, Shen SC, Lee WR, Lin HY, Ko CH, et al. (2002) Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21Cip1 protein in hepatocellular carcinoma cells SK-HEP-1. Arch Toxicol 76: 351-359. (Pubitemid 34639530)
32. Wang W, Guo Q, You Q, Zhang K, Yang Y, et al. (2006) Involvement of bax/bcl-2 in wogonin-induced apoptosis of human hepatoma cell line SMMC-7721. Anticancer Drugs 17: 797-805. (Pubitemid 44310176)
33. Tsai CF, Yeh WL, Huang SM, Tan TW, Lu DY (2012) Wogonin induces reactive oxygen species production and cell apoptosis in human glioma cancer cells. Int J Mol 8: 9877-92.
34. Chow SE, Chang YL, Chuang SF, Wang JS (2011) Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3b and DNp63. Cancer Chemother Pharmacol 68: 835-845.
35. Yu JS, Kim AK (2011) Wogonin induces apoptosis by activation of ERK and p38 MAPKs signaling pathways and generation of reactive oxygen species in human breast cancer cells. Mol Cells 31: 327-335.
36. Chen P, Lu N, Ling Y, Chen Y, Hui H, et al. (2011) Inhibitory effects of wogonin on the invasion of human breast carcinoma cells by down regulating the expression and activity of matrix metalloproteinase-9. Toxicology 282: 122-128.
37. Yang L, Zhang HW, Hu R, Yang Y, Qi Q, et al. (2009) Wogonin induces G1 phase arrest through inhibiting Cdk4 and cyclin D1 concomitant with an elevation in p21Cip1 in human cervical carcinoma HeLa cells. Biochem Cell Biol 87: 933-942.
38. Lee E, Enomoto R, Koshiba C, Hirano H (2009) Inhibition of P-glycoprotein by wogonin is involved with the potentiation of etoposide-induced apoptosis in cancer cells. Ann NY Acad Sci 1171: 132-136.
39. Ding J, Polier G, Köhler R, Giaisi M, Krammer PH, et al. (2012) Wogonin and related natural flavones overcome tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein resistance of tumors by down-regulation of c-FLIP protein and up-regulation of TRAIL receptor 2 expression. J Biol Chem 1: 641-9.
40. Song X, Yao J, Wang F, Zhou M, Zhou Y, et al. (2013) Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein. Toxicol Appl Pharmacol 2: 144-55.
41. Yang L, Wang Q, Li D, Zhou Y, Zheng X, et al. (2013) Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP proteins. Apoptosis 5: 618-26.
42. Li Q, Kluz T, Sun H, Costa M (2009) Mechanisms of c-Myc Degradation by Nickel Compounds and Hypoxia. PLoS ONE 4: e8531.